WitrynaDie IMCD Gruppe ist ein weltweiter Marktführer für Vertrieb, Marketing und Distribution von Spezialchemikalien und Ingredienzien. Mit einem globalen Netzwerk aus Branchenexperten bietet IMCD seinen Lieferanten und Kunden in den Regionen EMEA, Amerika und im asiatisch pazifischen Raum marktorientiere Lösungen sowie ein … WitrynaView the real-time IMCD NV (IMCD) share price and assess historical data, charts, technical analysis, performance reports and share chat forum. ... Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your ...
IMCD NV Historical Price Data (IMCD) - Investing.com
WitrynaThe EV/EBITDA NTM ratio of IMCD NV is significantly higher than the average of its sector (Specialty Chemicals): 7.70. According to these financial ratios IMCD NV's valuation is way above the market valuation of its sector. The EV/EBITDA NTM ratio of IMCD NV is lower than its historical 5-year average: 18.3. WitrynaIs IMCD stock a buy or sell? 100% free analysis on IMDZF, no signups required. Popular Screeners Screens. Biggest Companies Most Profitable Best Performing Worst Performing 52-Week Highs 52-Week Lows Biggest Daily Gainers Biggest Daily Losers Most Active Today Best Growth Stocks. ... Finance Charts. Finance ... cisplatin with radiation
Cristiano Bernini on LinkedIn: IMCD First Nine Months 2024 …
Witryna1 gru 2024 · IMCD N.V. has signed an agreement to acquire Welex S.A. Holdings Limited on June 21, 2024. Welex generated a revenue of approximately HKD 322 million in 2024 and has 68 employees. ... Financials . Sales 2024: 4 785 M 5 190 M 5 190 M: Net income 2024: 306 M 332 M 332 M: Net Debt 2024: 794 M 861 M 861 M: P/E ratio … WitrynaKey figures. *1. The period ended 31 December 2024 has been restated as a result of a change in accounting policy detailed in Note 2 to the financial statements included in … WitrynaView the latest IMCD N.V. (IMCD) stock price, news, historical charts, analyst ratings and financial information from WSJ. cisplatin weight loss